# Effect of Ipratropium Bromide on EILO

> **NCT07394036** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Cook Children's Health Care System** · enrollment: 50 (estimated)

## Conditions studied

- Exercise-Induced Laryngeal Obstruction
- Dyspnea During Activity

## Interventions

- **DRUG:** Ipratropium Bromide
- **DRUG:** Normal Saline (Placebo)

## Key facts

- **NCT ID:** NCT07394036
- **Lead sponsor:** Cook Children's Health Care System
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2029-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07394036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07394036, "Effect of Ipratropium Bromide on EILO". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07394036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*